Table 5 |
||||||
| Differential positive and negative effects experienced by participants | ||||||
| Full sample | Males | Females | ||||
| Placebo | Multi | Placebo | Multi | Placebo | Multi | |
| n = 59 | n = 55 | n = 28 | n = 24 | n =31 | n = 31 | |
| Positive experience | 50.8% | 60.0% | 64.3% | 62.5% | 38.7% | 58.1% |
| Mental/Cognitive Domain | ||||||
| General Mental Benefit | 8.5% | 9.1% | 7.1% | 0.0% | 9.7% | 16.1% |
| Improved Concentration, Attention &/or Memory | 8.5% | 9.1% | 10.7% | 20.8% | 6.5% | 0.0% |
| Increased Calmness or Relaxation | 20.3% | 14.5% | 21.4% | 25.0% | 19.4% | 6.5% |
| Better Mood & Emotional State | 8.5% | 23.6% * | 7.1% | 16.7% | 9.7% | 29.0% # |
| Physical Domain | ||||||
| General Physical Benefit | 8.5% | 5.5% | 14.3% | 12.5% | 3.2% | 0.0% |
| Improved Sleep | 5.1% | 15.5% # | 3.6% | 8.3% | 6.5% | 19.4% |
| More Energetic &/or Alert | 11.9% | 29.1% ** | 17.9% | 29.2% | 6.5% | 29.0% *** |
| Better Health &/or Immunity | 6.8% | 10.9% | 10.7% | 8.3% | 3.2% | 12.9% |
| Dermatological Benefit | 1.7% | 0.0% | 3.6% | 0.0% | 0.0% | 0.0% |
| Increased/Better Appetite | 1.7% | 1.8% | 3.6% | 4.2% | 0.0% | 0.0% |
| Negative experience | 28.8% | 30.9% | 25.0% | 25.0% | 32.3% | 35.5% |
| Mental/Cognitive Domain | ||||||
| Impaired Concentration/Attention | 5.1% | 3.6% | 3.6% | 4.2% | 6.5% | 3.2% |
| Stressed or Anxious | 1.7% | 3.6% | 0.0% | 0.0% | 3.2% | 6.5% |
| More Moody and Emotional | 1.7% | 5.5% | 3.6% | 0.0% | 0.0% | 9.7% |
| Physical Domain | ||||||
| Impaired Sleep | 1.7% | 1.8% | 3.6% | 0.0% | 0.0% | 3.2% |
| More Fatigued &/or Drowsy | 6.8% | 5.5% | 7.1% | 8.3% | 6.5% | 3.2% |
| Poorer Health &/or Immunity | 1.7% | 1.8% | 3.6% | 0.0% | 0.0% | 3.2% |
| Upper Gastrointestinal complaint | 1.7% | 9.1% | 0.0% | 8.3% | 3.2% | 9.7% |
| Indigestion or Nausea | 1.7% | 3.6% | 0.0% | 4.2% | 3.2% | 3.2% |
| Dermatological Complaint | 1.7% | 1.8% | 0.0% | 4.2% | 3.2% | 0.0% |
| Gynaecological Effect | 0.0% | 3.6% | - | - | 0.0% | 6.5% |
| Weight Gain | 3.4% | 1.8% | 3.6% | 0.0% | 3.2% | 3.2% |
*χ2(1)= 4.921, p = 0.027; ** χ2(1)= 5.245, p = 0.022; *** χ2(1) = 5.415, p = 0.020 #p = 0.05-0.10 (trend).
Sarris et al. Nutrition Journal 2012 11:110 doi:10.1186/1475-2891-11-110
